Product class:
|
Medicinal product with marketing authorization
|
Medicinal product class:
|
Veterinary medicine
|
Name of medicinal product:
|
Vitamin AD3E bela-pharm
|
Active substances:
|
|
ATC code:
|
QA11JA81
|
Dosage form:
|
solution for injection
|
Strength:
|
176,47mg+50mg+100mg 1ml
|
Legal status for supply*:
|
Subject to medicinal prescription
|
Summary of product characteristics (SPC):
|
(last updated September 29, 2021)
|
Package information leaflet (PIL):
|
EST (last updated September 29, 2021)
|
Labelling:
|
(last updated September 29, 2021)
|
Indication:
|
|
Safety features:
|
No
|
Marketing authorization holder:
|
Bela-Pharm GmbH & Co. KG
|
Marketing authorization number:
|
1994
|
Marketing authorization issued on:
|
September 30, 2016
|
Marketing authorization expires on:
|
Unlimited
|
Marketing authorization procedure type:
|
National
|
Assessment report:
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
1581252
|
Vitamin AD3E bela-pharm
|
solution for injection
|
176,47mg +50mg +100mg 1ml 100ml 1TK
|
Prescription
|
|
|
04.06.2021
|
|
|
1725926
|
Vitamin AD3E bela-pharm
|
solution for injection
|
176,47mg +50mg +100mg 1ml 100ml 6TK
|
Prescription
|
|
|
|
|
|
1725937
|
Vitamin AD3E bela-pharm
|
solution for injection
|
176,47mg +50mg +100mg 1ml 100ml 12TK
|
Prescription
|
|
|
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere